Foster & Motley Inc. Decreases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Foster & Motley Inc. lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the third quarter, Holdings Channel reports. The firm owned 34,213 shares of the company’s stock after selling 143 shares during the period. HCA Healthcare makes up approximately 0.9% of Foster & Motley Inc.’s investment portfolio, making the stock its 20th largest position. Foster & Motley Inc.’s holdings in HCA Healthcare were worth $13,905,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the stock. CreativeOne Wealth LLC acquired a new stake in HCA Healthcare during the 1st quarter worth $231,000. Bessemer Group Inc. raised its stake in HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after acquiring an additional 2,584 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of HCA Healthcare by 54.3% in the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock valued at $4,639,000 after purchasing an additional 4,893 shares during the period. Swedbank AB purchased a new position in HCA Healthcare in the 1st quarter valued at $95,882,000. Finally, EP Wealth Advisors LLC raised its position in HCA Healthcare by 1.6% during the 2nd quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock worth $72,335,000 after buying an additional 3,516 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Up 1.0 %

Shares of NYSE HCA opened at $366.66 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $226.44 and a 1 year high of $417.14. The firm has a market cap of $92.87 billion, a P/E ratio of 16.46, a price-to-earnings-growth ratio of 1.37 and a beta of 1.68. The firm’s 50 day moving average price is $392.01 and its 200 day moving average price is $355.77. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.72%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of several analyst reports. KeyCorp cut their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. TD Cowen dropped their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Royal Bank of Canada boosted their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $379.11.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.